Rapport Therapeutics, Inc. Common Stock (RAPP) stock news · $532.9M cap
Rapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company listed on US.
This RAPP news page leads with what Rapport Therapeutics, Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for RAPP yet. We will not pad this page with generic market recap.
Latest reported RAPP revenue for 2026-06-30 was $0. Net income was -$56.6M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. RAPP currently screens at market cap $532.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the RAPP stock page; for the tape open the quote page.
RAPP stock news FAQ
What is RAPP's latest net income?
Latest cached Rapport Therapeutics, Inc. Common Stock (RAPP) net income was -$56.6M. Statements: https://lician.com/financials/rapp
What is RAPP's market cap?
Rapport Therapeutics, Inc. Common Stock (RAPP) market cap is $532.9M on the latest cached fundamentals snapshot.
What kind of company is RAPP?
Rapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company listed on US.
Where is RAPP stock news listed?
Cached stock news for Rapport Therapeutics, Inc. Common Stock (RAPP) is listed at https://lician.com/news/rapp. Filings: https://lician.com/sec/rapp
Not investment advice.